Furthermore, emerging evidence has also connected hyperglycemia-instigated aberrant activation of P38 mitogen-activated protein kinase (P38 MAPK) with cardiac and vascular remodeling and dysfunction, while the inhibition of P38 MAPK prevents the development of DCM (3). This evidence concerns the gene MAPK14 and Hyperglycemia.